Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Rich Pharmaceuticals Inc RCHA

Healthcare Biotechnology
Rich Pharmaceuticals Inc is a United States based development stage biopharmaceutical company. It is focused on the development on RP-323 for the treatment of Hodgkin's lymphoma (HL), Acute Myelogenous Leukemia (AML), and to cause elevation of white blood cells in the patients depleted of these elements due to various conditions. RP-323 is a naturally occurring compound that has properties suited for the treatment of patients with HL, and AML. RP-323 has an ability to convert cancer cells to normal cells, a process called differentiation.


OTCPK:RCHA - Post by User

Rich Pharmaceuticals Inc
Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by iMarketcheck13on Feb 06, 2015 11:35pm
219 Views
Post# 23406468

Next big thing?!

Next big thing?!This thing is going to either explode in a few weeks or drop.... Worth the risk ? 
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities